Filing Details

Accession Number:
0000899243-16-023203
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-17 17:49:14
Reporting Period:
2016-06-15
Filing Date:
2016-06-17
Accepted Time:
2016-06-17 17:49:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042418 Hedgepath Pharmaceuticals Inc. HPPI Services-Commercial Physical & Biological Research (8731) 541641133
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1066040 Jr E Francis Odonnell 324 S. Hyde Park Avenue, Suite 350
Tampa FL 33606
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Per Share Disposition 2016-06-15 2,560,000 $0.00 11,440,000 No 4 S Indirect By Hopkins Capital Group II, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Hopkins Capital Group II, LLC
Footnotes
  1. On June 15, 2016, Hopkins Capital Group II, LLC ("HCGII") transferred 2,560,000 shares of common stock in satisfaction of $192,000 in then outstanding debt to an unrelated member HCGII who is not an affiliate of the issuer.
  2. The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.